Blog


The Mythology of Safe, Cheap Drugs from Canada

February 24, 2017

In January, the U.S. Senate rejected legislation, as it has multiple times in the past, which would have allowed the importation of prescription drugs from Canada.  Apparently believing that a … Continued


Walden Discussed Repeal and Replace Strategies at HLC Meeting

January 26, 2017

On January 24 at a dinner hosted by the Healthcare Leadership Council for its members, U.S. Representative Greg Walden (R-OR), the new chairman of the influential House Energy and Commerce … Continued


Expert Perspectives on an Uncertain Health Policy Future

December 5, 2016

As speculation heats up over how the new Trump administration and Congress will address healthcare in 2017, your time would be well spent viewing this Yahoo Finance video interview with … Continued


Addressing the Unintended Consequences of the Stark Law and Anti-Kickback Statute

October 12, 2016

In the new era of healthcare in which value-based care is steadily pushing aside the fee-for-service model, outdated rules and regulations continue to hinder the progress of healthcare reform. The … Continued


Patients Need Both Innovation and Accountability

September 29, 2016

Let’s begin this post by stipulating the concept behind the creation of the Center for Medicare and Medicaid Innovation (CMMI) is both sound and important. CMMI was created as part … Continued


The Challenge of Assessing Value in a Value-Based Healthcare System

September 21, 2016

The Healthcare Leadership Council released its National Dialogue for Healthcare Innovation (NDHI) policy recommendations earlier this year. One of the core policy reforms we advocate involves concrete steps to speed … Continued


Let the Public Option Rest in Peace

August 24, 2016

Most will remember that one of the most spirited debates during congressional consideration of the Affordable Care Act, back in the early days of the Obama administration, concerned the proposed … Continued


Campaigns, Honesty and the Future of Medicare

August 17, 2016

It’s like a bad rerun, but one with real consequences.  Every two years, some political candidates and the interest groups that support them decide the best way to boost their … Continued


A Decade of Proving Critics Wrong

July 27, 2016

As it was enacted into law in 2003, the Medicare prescription drug benefit, which would come to be known as Medicare Part D, had no shortage of critics.  A New … Continued


An Innovation-Centric Approach to Pricing and Accessibility

July 7, 2016

“Policy should not lose sight of the fact that new treatments represent miracles to many patients, and should encourage more, not less innovation.” With those words in her op-ed in … Continued